Financial Regulatory approves capital increase for Memphis Pharmaceutical, Egypt

Photo of blurred Pharmacy. Medical product shelves and entry doors. Getty Images Image used for illustrative purpose.
Getty Images

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940

Staff Writer, Arab Finance

July 22, 2024

PHOTO
Photo of blurred Pharmacy. Medical product shelves and entry doors. Getty Images Image used for illustrative purpose.

The Financial Regulatory Authority (FRA) has approved in principle for Memphis Pharmaceutical and Chemical Industries to invite senior shareholders to subscribe to the company’s rights issue, according to a statement.

Through the rights issue, the company seeks to raise its issued capital by EGP 171.25 million distributed over 17.125 million shares at a nominal value of EGP 10 per share.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO